RCS - Eco Animal Health Gp - Investor Presentation covering Full Year Results

ECO Animal HealthAnnouncement

05/09/2022 13:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220905:nRSE3011Ya&default-theme=true

RNS Number : 3011Y  Eco Animal Health Group PLC  05 September 2022

ECO Animal Health Group plc

(''ECO" or "the Group")

(AIM: EAH)

 

Investor Presentation covering Full Year Results

ECO Animal Health Group plc ("ECO" or "the Group"), a leader in the
development, registration and marketing of pharmaceutical products for global
animal health markets, is pleased to announce that David Hallas, CEO, and
Christopher Wilks, CFO, will be conducting a live presentation covering the
Group's Full Year Results for the period ended 31 March 2022.

The online presentation will take place on Wednesday 7 September at 10.00am
UK time. This event is open to all existing and potential shareholders and
registration is free. Questions can be submitted during the presentation and
will be addressed at the end of it.

 

To register for the event, please click here
(https://www.equitydevelopment.co.uk/news-and-events/ecoanimalhealth-fyresultspresentation-7sept2022)

 

A video recording of the presentation will be available shortly afterwards
here (https://www.equitydevelopment.co.uk/research/tag/eco-animal-health)

 

Contacts:

 

 ECO Animal Health Group plc                                    020 8447 8899

 David Hallas (Chief Executive)

 Christopher Wilks (Finance Director)

 IFC Advisory                                                   020 3934 6630

 Graham Herring

 Zach Cohen

 Singer Capital Markets (Nominated Adviser & Joint Broker)

 Mark Taylor                                                    020 7496 3000

 George Tzimas
 Investec (Joint Broker)

 Gary Clarence                                                  020 7597 5970

 Brough Ransom

 Carlo Spingardi

 Peel Hunt LLP (Joint Broker)

 Dr Christopher Golden                                          020 7418 8900

 James Steel

 

 Equity Development  020 7065 2692

 Hannah Crowe

 Matt Evans

 

About ECO Animal Health

 

ECO Animal Health Group plc ("ECO" or "the "GROUP") researches, develops and
commercialises products for livestock. Our business strategy is to generate
shareholder value by achieving the maximum sales potential from the existing
product portfolio whilst investing in Research and Development ("R&D") for
new products, particularly vaccines, and seeking to in-license new products

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEAFNSESXAEFA